News & Analysis as of

Pharmaceutical Industry › Nanotechnology

Bergeson & Campbell, P.C.

PCRM NURA Program Will Hold Webinar Series on Human-Based Methods in FDA Submissions

Bergeson & Campbell, P.C. on

The Physicians Committee for Responsible Medicine (PCRM) New Approach Methodologies (NAM) Use for Regulatory Application (NURA) program will hold a series of webinars on human-based methods in U.S. Food and Drug...more

Bergeson & Campbell, P.C.

NNI Webinar on Nanometrology for Nanoscale Medical and Pharmaceutical Products Will Be Held March 1, 2024

Bergeson & Campbell, P.C. on

The National Nanotechnology Coordination Office (NNCO) is organizing a series of National Nanotechnology Initiative (NNI) webinars on nanometrology, metrological challenges, and recent advances in three topical areas: food,...more

Bergeson & Campbell, P.C.

FDA NanoDay Symposium 2022 Will Be Held October 11, 2022

Bergeson & Campbell, P.C. on

The U.S. Food and Drug Administration (FDA) will hold the “FDA NanoDay Symposium 2022” on October 11, 2022. The symposium will address the following topics...more

Bergeson & Campbell, P.C.

FDA Will Hold NanoDay Virtual Research Symposium on October 9

Bergeson & Campbell, P.C. on

The U.S. Food and Drug Administration (FDA) Nanotechnology Task Force is celebrating NanoDay on October 9, 2020, by hosting a virtual research symposium to showcase more than a decade of progress and innovation in...more

Bergeson & Campbell, P.C.

EAASM Report on Patient Safety and Nanomedicines Calls for Centralized Regulatory Procedure

Bergeson & Campbell, P.C. on

On September 17, 2020, the European Alliance for Access to Safe Medicines (EAASM) announced the availability of a report entitled Patient Safety and Nanomedicines: The need for a centralised regulatory procedure. According...more

Bergeson & Campbell, P.C.

FDA Proposed Rule for OTC Sunscreen Drug Products Addresses Sunscreens Containing Nanomaterials

Bergeson & Campbell, P.C. on

The Food and Drug Administration (FDA) is scheduled to publish a proposed rule in the Federal Register on February 26, 2019, that would put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen...more

Knobbe Martens

Takeda Pharmaceuticals Explores GI Devices in New Partnership with Nanotechnology Company

Knobbe Martens on

Takeda Pharmaceutical Company, a Japan-based global pharmaceutical company, recently announced an agreement with BioSurfaces Inc., a small Massachusetts research company, to research the development of medical devices for the...more

Bergeson & Campbell, P.C.

Nanotechnology Startup Challenge for Cancer Will Bring Nanotechnology Inventions to Market

Bergeson & Campbell, P.C. on

On October 29, 2015, the White House Office of Science and Technology Policy (OSTP) published a blog item concerning the Nanotechnology Startup Challenge for Cancer (NSC2), “an open-innovation competition designed by the...more

Bergeson & Campbell, P.C.

Wrap-Up of Federal and State Chemical Regulatory Developments, September 2015

Bergeson & Campbell, P.C. on

EPA Releases TSCA Assessment Documents For Flame Retardant Chemicals: On August 18, 2014, the U.S. Environmental Protection Agency (EPA) released for public comment three Problem Formulation and Initial Assessment documents...more

Foley & Lardner LLP

Nanotech Drug Formulations Drive Dealmaking

Foley & Lardner LLP on

Some of the most commercially successful products to arise out of nanotechnology in terms of sheer size of revenues generated are nanotech drug formulations. This area continues to be hot in the wake of two recent deals, both...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide